BANK OF AMERICA CORP /DE/ - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 143 filers reported holding VIKING THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$7,663,472
+14.9%
692,274
+68.2%
0.00%0.0%
Q2 2023$6,669,864
-53.3%
411,466
-52.1%
0.00%0.0%
Q1 2023$14,289,780
+1468.8%
858,245
+785.7%
0.00%
Q4 2022$910,860
+184.6%
96,900
-17.7%
0.00%
Q3 2022$320,000
-8.3%
117,780
-2.5%
0.00%
Q2 2022$349,000
+129.6%
120,861
+139.0%
0.00%
Q1 2022$152,000
-39.4%
50,563
-7.4%
0.00%
Q4 2021$251,000
-86.3%
54,621
-81.3%
0.00%
Q3 2021$1,837,000
+10.4%
292,582
+5.3%
0.00%
Q2 2021$1,664,000
-32.4%
277,743
-28.6%
0.00%
Q1 2021$2,461,000
+74.4%
389,086
+55.3%
0.00%
Q4 2020$1,411,000
-19.1%
250,618
-16.4%
0.00%
Q3 2020$1,745,000
-18.5%
299,918
+1.0%
0.00%
Q2 2020$2,141,000
+62.9%
297,013
+5.7%
0.00%
Q1 2020$1,314,000
-38.8%
280,959
+4.9%
0.00%
Q4 2019$2,148,000
-0.6%
267,879
-14.7%
0.00%
Q3 2019$2,160,000
-52.6%
314,150
-42.7%
0.00%
-100.0%
Q2 2019$4,555,000
-49.1%
548,595
-39.0%
0.00%0.0%
Q1 2019$8,945,000
+363.0%
900,014
+256.3%
0.00%
Q4 2018$1,932,000
+973.3%
252,609
+2349.4%
0.00%
Q3 2018$180,000
+80.0%
10,313
-1.6%
0.00%
Q2 2018$100,000
+40.8%
10,486
-35.6%
0.00%
Q1 2018$71,00016,2760.00%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Affinity Asset Advisors, LLC 622,249$10,360,4463.42%
GREAT POINT PARTNERS LLC 1,000,000$16,650,0003.27%
Ghost Tree Capital, LLC 600,000$9,990,0002.95%
SILVERARC CAPITAL MANAGEMENT, LLC 380,000$6,327,0002.61%
Integral Health Asset Management, LLC 727,100$12,106,2152.44%
Sio Capital Management, LLC 250,000$4,162,5002.06%
Boxer Capital, LLC 2,000,000$33,3001.64%
DAFNA Capital Management LLC 319,155$5,313,9311.59%
5AM Venture Management, LLC 350,000$5,827,5001.49%
Monashee Investment Management LLC 300,000$4,995,0001.38%
View complete list of VIKING THERAPEUTICS INC shareholders